October 2015 Analysis

Industry Trend Analysis - EMA's HPV Vaccine Safety Review Will Have Little Impact On Sales - OCT 2015

This review by the EMA will have little to no impact on the sales of Merck's Gardasil franchise or GlaxoSmithKline's Cervarix sales. The benefits of the vaccines outweigh the risks, and the two conditions supposedly linked to the vaccines are very rare and can occur in non-vaccinated individuals, which will lead to little change in prescribing information for the products.